Standard BioTools Inc.LABNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +65.74% | -10.42% | -3.25% | -56.52% | -93.10% |
| Gross Profit Growth | +64.00% | -18.39% | +2.45% | -59.23% | -87.72% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +369.77% | +28.59% | +2.19% | +2.99% | +2.80% |
| Weighted Average Shares Diluted Growth | +369.77% | +28.59% | +2.19% | +2.99% | +2.80% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +70.95% | -1.48% | -54.96% | -61.67% | -60.04% |
| Inventory Growth | +98.40% | +4.38% | -43.29% | -40.39% | -50.95% |
| Asset Growth | +89.54% | -25.47% | -21.41% | -20.82% | -7.28% |
| Book Value per Share Growth | -38.47% | -38.77% | -18.59% | -20.69% | -12.51% |
| Debt Growth | -66.40% | -65.69% | -68.40% | -69.39% | -6.57% |
| R&D Expense Growth | +103.40% | -29.11% | -14.11% | -51.69% | -43.29% |
| SG&A Expenses Growth | +76.02% | -17.54% | +13.05% | -22.70% | -32.59% |